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1. Introduction 
Proflavine belongs to a group of chemically syn- 
thesized drugs, the acridines, which binds nucleic 
acids and has been used as a biochemical tool to study 
the properties of DNA and RNA in vivo and in vitro 
[ 1 ] The binding of proflavine to the bacterial chro- 
mosome results in a rapid inhibition of the DNA 
dependent RNA synthesis and has therefore provided 
a means to study enzyme synthesis in the absence of 
transcription [2]. During the course of some experi- 
ments on the catabolite repression of the enzyme tryp- 
tophanase we have found that the cyclic nucleotide 
adenosine-3’, 5’-monophosphate (CAMP) hinders the 
uptake of proflavine by Escherichia coli during growth. 
We have also found that the overall synthesis of RNA 
and protein are inhibited by proflavine to a lesser 
degree when CAMP is present. The significance of our 
findings is apparent since proflavine together with 
CAMP has been used in earlier studies [3-51 in dis- 
cerning the role of CAMP in the synthesis of catabolite 
repression sensitive enzymes. 
2. Experimental 
The strain used in this work, Escherichia coli 
RS 1, and the culture medium have been described 
previously [6] . Cells in the exponential phase, grown 
b;n glycerol at 37”, were used in all the experiments 
(about 3.5 X 10’ cells/ml). Absorbance was measured 
with a Gilford model 2400 spectrophotometer and 
absorption spectra were recorded using a Cary 15 
spectrophotometer. Radioactivity was estimated in a 
low background Nuclear Chicago gas flow counter. 
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Freshly prepared proflavine hydrochloride solu- 
tions (1 mg/ml in 0.1 M potassium phosphate, pH 
7.8) were freed of the undissolved residue by centri- 
fugation prior to use. For the estimation of proflavine 
uptake, 2.5 ml samples of the culture containing the 
drug were withdrawn, chilled and centrifuged in the 
cold (10 min at 20,000 g). The sediments were 
suspended in 2.5 ml of cold 0.1 M potassium phos- 
phate, pH 7.8, centrifuged, the colourless supernatants 
discarded, and the cells were resuspended in 2.5 ml of 
the same buffer solutions. These cell suspensions were 
disrupted by ultrasonic treatment and clarified by 
centrifugation (15 min at 27,000 g). Proflavine was 
estimated in the supernatans by measuring their 
absorbance at 444 nm. 
RNA synthesis was followed by the incorporation 
ofuracil-‘4C into trichloroacetic acid (TCA) precipi- 
tate. 0.5 ml samples of the labelled uracil containing 
culture were added to 0.5 ml aliquots of ice-cold 1% 
TCA. The precipitates were collected on Whatman 
GF/C filters previously soaked in 5% TCA and washed 
twice on the filters with 5 ml of cold 5% TCA. The 
filters were placed on planchets, dried and analyzed 
for radioactivity. 
Protein synthesis was estimated by the incorpora- 
tion of L-leucine-‘4C into hot TCA precipitate. 1 .O ml 
samples of the labelled leucine containing culture were 
added to 1 ml aliquots of 1% TCA and the mixtures 
were heated in a water bath for 15 min at 85-90”. 
After this step the procedure was essentially similar 
to the one used for uracil incorporation. 
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3. Results 
While investigating the role of CAMP on the synthesis 
of tryptophanase by E. coli we observed that the 
yellow colour of a proflavine solution was slightly 
altered on addition of CAMP. The difference absorp- 
tion spectrum of proflavine (0.1 mg/ml) minus prof- 
lavine together with CAMP (5 mM) showed a peak 
around 410 nm and a trough around 470 nm, indicating 
a shift towards longer wavelengths of the absorption 
maximum of proflavine (444 nm) which probably 
reflects a chemical interaction between the drug and 
Table 1 
Effect of CAMP on the uptake of proflavine by Escherichia 
coli cells. 
Incubation time Proffavine uptake (&ml culture) 
(min) 
Without CAMP With CAMP 
0.5 1.9 0.5 
5.0 2.8 0.8 
Proflavine (0.1 mg/ml) and CAMP (5 mM) were added at zero 
time and samples were withdrawn as indicated. Other condi- 
tions are described in sect. 2. 
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Fig. 1. Effect of CAMP on the residual incorporation of uracil 
after proflavine addition. Uracil-r4C (0.55 J.&I, 60 mCi/mmole), 
proflavine (0.1 mg/ml) and CAMP (5 mM) were added at zero 
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Fig. 2. Effect of CAMP on the residual incorporation of 
leucine after proflavine addition. L-leucine-14C (0.1 mM, 0.2 
mCi/mmole), proflavine (0.1 mgjml) and CAMP (5 mM) were 
added at zero time. Other conditions are described in sect. 2. 
0 3 6 9 12 15 
minutes 
Fig. 3. Effect of CAMP on the residual incorporation of 
leucme after rifampicin addition. L-leucine14C (0.1 mM, 0.2 
mCi/mmole), rifampicin (0.3 mg/ml) and CAMP (5 mM) were 
added at zero time. Other conditions are described in sect. 2. 
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the nucleotide. These observations suggested that 
CAMP might influence the uptake of proflavine by 
E. coli cells. As seen from table 1,30 set after the 
addition of proflavine and CAMP the amount of the 
drug which remained bound to the cells in the pre- 
sence of CAMP was only about 30% of that bound in 
the absence of the nucleotide. Even after five min the 
uptake of the drug was inhibited by CAMP to the 
same extent. 
To check whether the effect of CAMP on proflavine 
uptake altered the ability of the latter to inhibit RNA 
synthesis, we studied uracil incorporation in the 
presence of both the dye and the nucleotide. A rapid 
decrease in TCA precipitable counts has been observed 
with proflavine when uracil was present before the in- 
hibitor [2] . However, some uracil was still incorporated 
when uracil and proflavine were added at the same 
time; fig. 1 shows that CAMP increased the rate of 
RNA synthesis under these conditions. Since the overall 
synthesis of RNA is not stimulated by CAMP in un- 
inhibited cultures [7] , the effect of CAMP on the in- 
hibition by proflavine is very likely the result of a 
decrease in the incorporation of the inhibitor in the 
presence of the nucleotide (table 1). 
In order to determine whether CAMP had any 
effect on protein synthesis in cultures inhibited by 
proflavine we studied the kinetics of leucine incorpor- 
ation in the presence and absence of the nucleotide. 
As seen from fig. 2 leucine incorporation was about 
150% greater in the presence than in the absence of 
CAMP. Although these results appear to be a conse- 
quence of a decrease in the inhibition of RNA syn- 
thesis by proflavine in the presence of CAMP (fig. 1) 
this could have been also due to the overall stimulation 
of protein synthesis by CAMP at the level of the poly- 
some. Such a stimulation has not been detected in 
growing cells [7] but it could occur when RNA syn- 
thesis was impaired. To test this possibility we studied 
the kinetics of leucine incorporation after inhibiting 
RNA synthesis with rifampicin. This drug binds the 
bacterial RNA polymerase and seems to block one of 
the initial steps of transcription in cell-free extracts 
[8] as well as in intact cells [9]. The results, presented 
in fig. 3, show no difference in the residual incorpora- 
tion of leucine in the presence or absence of CAMP 
and support the postulate that CAMP does not stimulate 
protein synthesis when the bulk of RNA synthesis is 
inhibited. It appears, therefore, that the enhancement 
of leucine incorporation by CAMP observed in the 
presence of proflavine (fig. 2) was due to the impaired 
drug uptake caused by the nucleotide. 
4. Concluding remarks 
CAMP plays an important regulatory role in the 
normal expression of catabolite repression sensitive 
bacterial genes [lo] . The stimulation of enzyme syn- 
thesis by CAMP after the blockage of transcription by 
proflavine has been taken as a proof that CAMP is 
required at a translational step [4,5]. However, our 
findings suggest hat the effect of CAMP after proflavine 
addition is not related to the mechanism of catabolite 
repression. Therefore proflavine should not be used 
together with CAMP unless the particular experimental 
conditions ensure that the interference is eliminated. 
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